Abstract
No public abstract is available from the verified source records.
Pascal Vranckx, David Morrow, Sean van Diepen, Frederik H Verbrugge
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks
2026
Antithrombotic therapy in patients with acute coronary syndrome: similarities and differences between a European expert consensus document and the 2023 European Society of Cardiology guidelines
2024
Antithrombotic therapy in patients with chronic coronary syndrome: a focus on the 2024 European Society of Cardiology guidelines
2025
Association between haemolysis markers and neuron-specific enolase in acute myocardial infarction complicated by cardiogenic shock patients supported with a microaxial flow pump
2025
The association of early or late combined infection with clinical outcomes in cardiogenic shock patients
2026
C-reactive protein levels and outcomes in infarct-related cardiogenic shock: data from the ECLS-SHOCK trial
2025
Cardiogenic shock as a complication of acute myocardial infarction: a nationwide cohort study
2026
Cardiogenic shock in general intensive care unit: a nationwide prospective analysis of epidemiology and outcome
2024
Clinical characteristics, management, and predictors of mortality: results from the national prospective cardiogenic shock registry (CZECH-SHOCK)
2025
Comparison of 1-month vs. 12-month dual antiplatelet therapy after implantation of drug-eluting stents in patients with acute coronary syndrome: the ULTIMATE-DAPT trial
2024
Development and validation of a risk score in acute myocardial infarction-related cardiogenic shock
2025
Epidemiology of cardiogenic shock using the Shock Academic Research Consortium (SHARC) consensus definitions
2024
Escalation of mechanical circulatory support in patients with STEMI-related cardiogenic shock: a post hoc analysis of the DanGer Shock trial
2026
Long-term outcomes after acute kidney injury in myocardial infarction complicated by cardiogenic shock: a retrospective, observational study
2025
Managing bleeds on anticoagulant therapy: a practical guide for clinicians
2026
The microcirculation in cardiogenic shock
2024
Mild induced hypothermia in patients with infarct-related cardiogenic shock and cardiac arrest: insights from the CULPRIT-SHOCK trial
2026
Model for end-stage liver disease incorporating albumin score is associated with short- and long-term all-cause mortality in patients with acute myocardial infarction complicated by cardiogenic shock
2025
Now it is time to show courage!
2026
Outcomes of patients with cancer admitted with heart failure-associated cardiogenic shock
2025
Pharmacodynamic effects of cangrelor in patients with or without STEMI undergoing percutaneous coronary intervention: insights from the POMPEII study
2026
Targeted proteomic profiling of cardiogenic shock in the cardiac intensive care unit
2024
Associations between admission C-reactive protein and in-hospital mortality amongst patients with cardiogenic shock
10.1093/ehjacc/zuag083 · 2026
Summed QRS amplitude on electrocardiogram 1 week after admission and in-hospital outcomes in patients with fulminant myocarditis
10.1093/ehjacc/zuag092 · 2026
One-year and 5-year transition risks between major bleeding, reinfarction and death following acute myocardial infarction in England and Wales: a population-based cohort study
10.1093/ehjacc/zuag088 · 2026
Beyond A and B: exploring a novel dynamic ECG change in Wellens syndrome
10.1093/ehjacc/zuag102 · 2026
Cardiac mechanical efficiency in patients with cardiogenic shock
10.1093/ehjacc/zuag098 · 2026
Prognostic impact of pericardial effusion in patients with acute myocarditis
10.1093/ehjacc/zuag090 · 2026
Inflammation in coronary syndromes in clinical practice: a clinical consensus statement of the Association for Acute Cardiovascular Care of the European Society of Cardiology, the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, the European Society of Cardiology Council on Basic Cardiovascular Science, and the European Society of Cardiology Council for Cardiology Practice
10.1093/ehjacc/zuag086 · 2026
Inflammation in cardiogenic shock: a marker of outcome, not yet a treatment target
2026
No additional external references are available.